AAP Implantate AG/ DE000A3H2101 /
| - - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| -EUR | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 5.16 mill.EUR | 0.00% | - |
Fundamentals
| FY 2021 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | -0.51 EUR | -81.72% |
| EPS Diluted: | -0.51 EUR | -81.72% |
| Revenues per Share: | 2.08 EUR | -28.22% |
| Book Value per Share: | 2.18 EUR | -32.00% |
| Cash Flow per Share: | -0.43 EUR | -63.03% |
| Dividend per Share: | 0.00 EUR | - |
| Total | in mill. | |
| Revenues: | 12.20 EUR | 31.18% |
| Net Income: | -2.70 EUR | -69.32% |
| Operating Cash Flow: | -2.50 EUR | - |
| Cash and Cash Equivalents: | 2.10 EUR | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | 0.42 | 1.44 |
| P/BV ratio: | 0.40 | 1.37 |
| P/CF Ratio: | -2.06 | -7.03 |
| PEG: | 0.02 | - |
| Earnings Yield: | -57.95% | -17.00% |
| Dividend Yield: | 0.00% | 0.00% |
| Market Capitalization | ||
| Market Capitalization: | 5.16 mill. EUR | 17.58 mill. EUR |
| Free Float Market Cap.: | 2.61 mill. EUR | 8.91 mill. EUR |
| Market Cap. / Employee: | 47,318.1651 EUR | 161,311.9266 EUR |
| Shares Outstanding: | 5.86 mill. | |
Profitability
| Gross Profit Margin: | 30.19% |
| EBIT Margin: | -21.31% |
| Net Profit Margin: | -22.13% |
| Return on Equity: | -21.09% |
| Return on Assets: | -11.74% |
Financial Strength
| Liquidity I / Cash Ratio: | 33.33% |
| Liquidity II / Quick Ratio: | 82.54% |
| Liquidity III / Current Ratio: | 211.11% |
| Debt / Equity Ratio: | 79.69% |
| Dynam. Debt / Equity Ratio: | -408.00% |
Efficiency
| Employees: | 109 |
| Personal Expenses / Employee: | 61,623.85 EUR |
| Revenues / Employee: | 111,926.61 EUR |
| Net Income / Employee: | -24,770.64 EUR |
| Total Assets / Employee: | 211,009.17 EUR |
| * Fiscal Year End: | 2021-12-31 |
| Accounting Standard: | IFRS |
| Currency: | EUR |
